Journals / Anadolu Kardiyoloji Dergisi / 2014 / Cilt: 14 - Sayı: 3

Left ventricular diastolic dysfunction: A new foe in the management of atrial fibrillation?

Pages
261–264
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

IWAKURA, K. (2022). Left ventricular diastolic dysfunction: A new foe in the management of atrial fibrillation?. Anadolu Kardiyoloji Dergisi, Cilt: 14 - Sayı: 3, 261–264. https://ajindex.com/articles/436093

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Chugh S, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin E, et al. Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study. Circulation 2014
  2. [CrossRef] 2. Go A, Mozaffarian D, Roger V, Benjamin E, Berry J, Blaha M, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014
  3. e28-92. [CrossRef] 3. Wolf P Abbott R, Kannel W. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991
  4. [CrossRef] 4. Hart R, Pearce L, Rothbart R, McAnulty J, Asinger R, Halperin J. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 2000
  5. [CrossRef] 5. Lin H, Wolf P Kelly-Hayes M, Beiser A, Kase C, Benjamin E, et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996
  6. [CrossRef] 6. Gattellari M, Goumas C, Aitken R, Worthington J. Outcomes for patients with ischaemic stroke and atrial fibrillation: the PRISM study (A Program of Research Informing Stroke Management). Cerebrovasc Dis 2011
  7. [CrossRef] 7. Hart R, Pearce L, Aguilar M. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007
  8. [CrossRef] 8. Penado S, Cano M, Acha O, Hernández J, Riancho J. Atrial fibrillation as a risk factor for stroke recurrence. Am J Med 2003
  9. [CrossRef] 9. Gattellari M, Worthington J, Zwar N, Middleton S. Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians. Stroke 2008
  10. [CrossRef] 10. Lip G, Laroche C, Dan G, Santini M, Kalarus Z, Rasmussen L, et al. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP- AF) Pilot General Registry. Europace 2014
  11. [CrossRef] 11. Reynolds M, Shah J, Essebag V, Olshansky B, Friedman P Hadjis T, et al. Patterns and predictors of warfarin use in patients with new- onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol 2006
  12. [CrossRef] 12. Lamassa M, Di C, Pracucci G, Basile A, Trefoloni G, Vanni P et al. Characteristics, outcome, and care of stroke associated with atrial fibrillat